• <lw class="guttm"></lw>

    k8·凯发天生赢家·一触即发(中国区)官方网站

    Yueping ZHONG Chief Executive Officer
    Law Firm Management and Operations
    +86 10 5650 0898 yueping.zhong@yuanfo.net Beijing

    Yueping Zhong is a partner at the Beijing Office of Merits & Tree Law Offices. Prior to joining Merits & Tree, Ms. Zhong worked in Han Kun Law Offices, Herbert Smith Freehills and Fangda Partners.

     

    Ms. Zhong specializes in legal services for PE/VC, M&A, and License in/out. In the past over a decade of practice, she has been focusing on the industry of life science and new technologies. In the sector of PE/VC, Ms. Zhong has acted for institutional investors, start-up companies, and industry-leading enterprises, where she participates in some high-profile deals. In the sector of license in/out, with profound knowledge of life science industry, as an industry with high threshold, long life cycle, regulation-driven and global footprint, Ms. Zhong excels in providing one-stop legal services to protect clients’ interests and resolve transactional complication.

    Achievements
    Private Equity Investment
    • Advising DiDi Taxi on its A round financing, B round financing and C round financing
    • Advising Yooli on its A round financing and B round financing
    • Advising ZCool on its A round financing, B round financing, B+ round financing and C round financing
    • Advising Jinfuzi on its C round financing and D round financing
    • Advising Happy Elements on its strategic investment
    • Advising Sequoia Capital on pharmaceutical companies, including Recbio, Fapon Biotech, etc.
    • Advising IDG Ventures on its investments in bio-pharmaceutical companies (eg. Gensciences) and IVD companies
    • Advising OrbiMed on its investment in AnchorDx, a world-leading developer of cancer screening and early detection solutions
    • Advising Zhen Fund on its investment on Pinnacles Medical, a new generation of intelligent diagnosis IVD leading enterprise
    • Advising KTB Ventures on its investment in a bio-pharmaceutical company
    Mergers & Acquisitions
    • Advising on the acquisition of CodeMonkey, an Israeli coding education company, by TAL Education Group on behalf of the TAL Education Group
    • Advising on the acquisition of a cloud computing company by Ant Financial on behalf of the selling shareholders
    • Advising on the acquisition of a SAAS company by Tencent on behalf of the selling shareholders
    • Advising on the acquisition of ZTE’s “Global Eye” business on behalf of Unitas Capital
    • Advising on the acquisition of a leading Chinese fire protection products by Xtralis (an Australian listed company) on behalf of the selling shareholders
    • Advising on the acquisition of a Chinese leading processor supplier by Cavium Inc (NDAQ: CAVM)’s on behalf of the selling shareholders
    • Advising on acquisition of a Chinese leading online advertising company by Aegis Group(listed on LSE)on behalf of the selling shareholders
    License in/out
    • Advising Junshi Biosciences on licensing-out an anti-cancer drug to an American Bio-pharmaceutical company
    • Advising InfiBrainTech(IBT) on licensing-out a neurological digital therapy
    • Advising PVmed on licensing-out a medical imaging diagnosis software to an American medical technology company
    • Advising a domestic pharmaceutical company on licensing-in a series of anti-cancer drugs from Israel
    • Advising a domestic bio-pharmaceutical company on licensing-in a monoclonal antibody biosimilar
    Honors
    • 2022 Legal 500 Private Equity - Recommended Lawyer
    • 2020-2023 LEGALBAND Top Ranked Lawyers - Healthcare & Life Sciences
    • 2022 LEGALBAND Special Issue: China Top 15 Lawyers - Healthcare & Pharmaceuticals
    • 2020 LEGALBAND Client Choice: Top 15 Female Lawyers
    Education
    • LL.M., Boston University
    • LL.B., China University of Political Science and Law
    Admissions
    • PRC Bar
    • New York State Bar
    Language
    Chinese  English  Cantonese

    One-stop legal services, with you every step of the way.

    Subscribe
    *
    *
    *
    *
    *
    *
    Click Refresh
    Business areas that interest you (multiple choices)
    The industry field you are interested in (multiple choices)
    Reminder:
    Submitting this form is considered as your request to receive industry research reports and publications from Zhi De Law Firm.
    Disclaimers:
    The industry research reports and publications you subscribe to do not represent the legal opinions of Zhide Law Firm on relevant issues. If you need legal advice, please consult or seek assistance from qualified professionals.
    WeChat official account
    友情链接: